Quality Regulations: Unterschied zwischen den Versionen
K |
|||
| (Eine dazwischenliegende Version desselben Benutzers wird nicht angezeigt) | |||
| Zeile 34: | Zeile 34: | ||
== United Kingdom (UK) == | == United Kingdom (UK) == | ||
| − | MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials' | + | MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials', March 2020 |
| − | [https://www.gov.uk/government/publications/supply-unlicensed-medicinal-products-specials MHRA Guidance] | + | [https://www.gov.uk/government/publications/supply-unlicensed-medicinal-products-specials MHRA Guidance] (website) |
| + | |||
| + | [https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/869284/Cannabis_Guidance__unlicensed_CBPMs__updated_2020.pdf The supply of unlicensed cannabis-based products for medicinal use in humans], 2020 (document) | ||
| + | |||
| + | [https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/373505/The_supply_of_unlicensed_medicinal_products__specials_.pdf The supply of unlicensed medicinal products 'specials", MHRA Guidance Note 14], 2014 (document) | ||
Aktuelle Version vom 18. Oktober 2021, 14:07 Uhr
Inhaltsverzeichnis
Scope[Bearbeiten]
Regulations for Cultivation & Collection[Bearbeiten]
WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants, 2003 (Link to WHO)
Regulations for Processing, Packaging and Storage[Bearbeiten]
Requirements Health Canada[Bearbeiten]
Health Canada's Cannabis Regulations SOR/2018-144 requires surveillance of the premises in section 64-66.
GAP Canada Version (current Version 9.0 – April 1, 2021) A revision is usually done in February each year.
Health Canada; Good Manufacturing Practices (GUI-0001); July 1, 2020
European Union[Bearbeiten]
Reflection paper on microbiological aspects of herbal medicinal products and traditional herbal medicinal products
Application requirements for cannabis cultivation, processing and medical sales licences[Bearbeiten]
Requirements Health Canada[Bearbeiten]
Application requirements for cannabis cultivation, processing and medical sales licences
United Kingdom (UK)[Bearbeiten]
MHRA Guidance on manufacturing, importing, distributing and supply specially manufactured or ordered products, including cannabis-based products for medicinal use in humans (CBPMs), known as 'specials', March 2020
MHRA Guidance (website)
The supply of unlicensed cannabis-based products for medicinal use in humans, 2020 (document)
The supply of unlicensed medicinal products 'specials", MHRA Guidance Note 14, 2014 (document)